How Liraglutide Briefly Rewires Gut Microbiome: Mouse Study Findings
Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), triggers rapid but largely reversible shifts in the gut microbiome of obese mice, according to a study published in the journal Microbiology Spectrum. Researchers found that while the drug alters bacterial community structure during active treatment, these changes largely normalize within seven days of discontinuing the medication. … Read more